Women & Infants Seeks Menopausal Women for National Study
Saturday, September 10, 2011
The hospital is participating in a national, randomized study, sponsored by EndoCeutics, to investigate the efficacy of a new medication for menopausal experiences of vaginal dryness, vaginal or vulvar irritation or itching, or pain associated with sexual activity. Women who are postmenopausal and ages 40 to 75 years may be eligible to participate and may receive financial compensation up to $650.
No reason to not enjoy sexual activity because of menopause
"Just because a woman has gone through menopause does not mean that she has to feel physically uncomfortable, nor should she no longer be able to enjoy sexual activity,” says John Buster, MD, lead investigator and a reproductive endocrinologist in the Center for Reproduction and Infertility at Women & Infants Hospital and professor of obstetrics and gynecology at The Warren Alpert Medical School of Brown University and Tufts Medical Center. “We are studying a simple, hormone-based cream to determine the best dosage and timing to provide the most relief for women.”
During the three-month study, participants will apply a vaginal ovule containing DHEA, the hormone being investigated, or a placebo once daily for two weeks and then twice weekly for 10 weeks.
Patients are now being enrolled at the hospital’s Center for Reproduction and Infertility in Providence, Boston and 11 other locations. For information, call the research nurse, Emily, at 274-1122, extension 8422, or visit womenandinfants.org/infertility.
Related Articles
- NEW: 37 Women & Infants Docs Named Tops by US News
- Women and Infants Participating in National Study of New Fertility Drug
- Nursing Team at Women and Infants Honored in Modern Healthcare
- Women & Infants Named Center of Excellence for Reproductive Resources
- Women & Infants Named Neonatal Center of Excellence
- Women & Infants New Program for High-Risk Pregnancies
Follow us on Pinterest Google + Facebook Twitter See It Read It